Exane Asset Management Pfizer Inc Transaction History

Exane Asset Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 24, 2019	SELL	$32.49 - $42.13 $2.59 Million - $3.36 Million	-79,861 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $175,285 - $196,804	4,740 Added 6.31%	79,861 $0
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $2.82 Million - $3.09 Million	75,121 New	75,121 $0
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $461,640 - $526,320	-12,000 Closed	0 $0
Q3 2018 Nov 16, 2018	BUY	$34.47 - $41.81 $413,640 - $501,720	12,000 New	12,000 $0

3,164

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.